Markerless lung tumor localization in cine MV images of deep-inspiration breath-hold IMRT treatments
MO-0470
Abstract
Markerless lung tumor localization in cine MV images of deep-inspiration breath-hold IMRT treatments
Authors: Sky Rohrer1,2, Ditte Sloth Møller3,4, Lone Hoffmann4,3, Simon Skouboe1, Mai Lykkegaard Ehmsen1, Thomas Ravkilde4, Marianne Knap3, Per Rugaard Poulsen1,3
1Aarhus University Hospital, Danish Center for Particle Therapy, Aarhus, Denmark; 2University of Zurich, Physik-Institut, Zurich, Switzerland; 3Aarhus University Hospital, Department of Oncology, Aarhus, Denmark; 4Aarhus University Hospital, Department of Medical Physics, Aarhus, Denmark
Show Affiliations
Hide Affiliations
Purpose or Objective
Radiotherapy of lung
cancer often involves considerable irradiation doses to normal tissue because
safety margins are needed to account for respiratory motion and other
geometrical uncertainties. Treatment in deep inspiration breath-hold (DIBH) may
reduce the motion and the needed margins. However, poor correlation between the
external signal used to gate the DIBH treatment and the internal target
position can limit the targeting accuracy and thus the benefit of the DIBH
treatment. In this study, we develop a method for markerless lung tumor
localization in cine MV images of IMRT treatment fields and demonstrate use of
the method to determine the tumor position error during DIBH treatments.
Material and Methods
25 lung cancer patients were treated with IMRT in DIBH in 20-33 fractions with daily cone-beam CT (CBCT) guided setup based on the primary tumor. Cine MV images were recorded for all treatment fields at most fractions. Post-treatment, the shift of the tumor position in the MV images relative to the intended position from the CBCT setup procedure was found as described in the following and summarized in Fig 1. First the individual cine MV frames with IMRT segments were pieced together to form a composite MV image that covered the entire MV beam aperture (L1 in Fig 1). Here, the possible tumor motion during the DIBH field delivery was neglected. Next, an in-house developed ray tracing algorithm was used to generate digitally reconstructed radiographs (DRRs) based on the entire CBCT (DDRtotal), a slab of the CBCT near the isocenter plane containing the tumor volume (DDRtumor), and the entire CBCT except for the tumor containing slab (DDRnon-tumor) (L2). All DRRs were rescaled to have similar contrasts as the composite cine MV image (L3). DDRnon-tumor was then subtracted from the composite cine MV image to generate a tumor-enhanced cine MV image (L4) in which the tumor position was found by template-based segmentation (L6) using the projected tumor shape in DDRtumor as template (L5). The tumor segmentation has been performed for one patient at the time of abstract deadline and is currently being extended to all 25 patients.
Results
Figure 2A shows examples of the CBCT-based tumor template and 2B shows the
tumor-enhanced cine MV image with the segmented tumor position. In this case,
the internal tumor shift in the patient between setup CBCT and treatment
delivery was 2.9 mm in the cranial direction. Figure 2C shows the tumor shift
at all imaged fractions for this patient. The mean shift was 3.4 mm (SD = 2.1 mm).
Conclusion
A method for markerless lung tumor localization in
cine MV images was developed and applied to determine the intrafraction tumor
shift between setup imaging and treatment delivery in lung cancer DIBH IMRT
treatments. The method is well-suited for DIBH treatments, where the
optimally small residual lung tumor motion during IMRT field delivery allows
generation of a composite cine MV image from the IMRT segments.